Head Acupuncture Treat Residual Symptoms After Canalith Repositioning Procedure for BPPV
Benign Paroxysmal Positional Vertigo
About this trial
This is an interventional treatment trial for Benign Paroxysmal Positional Vertigo
Eligibility Criteria
Inclusion Criteria: According to the diagnostic criteria and therapeutic efficacy evaluation for benign paroxysmal positional vertigo (BPPV) formulated by the Otolaryngology-Head and Neck Surgery Branch of the Chinese Medical Association, the patient was confirmed as having BPPV and the repositioning maneuver was successful. After the maneuver, the patient's clinical symptoms were relieved, with no sense of rotation or dizziness, but residual symptoms such as discomfort and unsteady gait persisted. There were no obvious communication barriers or visual impairments. The patient and their family members agreed to the treatment plan. Exclusion Criteria: Patients with other ear diseases, history of head trauma or surgery; Patients who are weak and unable to tolerate, pregnant women; Patients who have undergone vestibular rehabilitation training before this treatment; ④ Patients with joint diseases that affect balance and walking; ⑤ Patients with a history of brain organic diseases (such as tumors, stroke, cerebral hemorrhage) or severe neurological diseases; ⑥ Patients with incomplete data or who withdraw from treatment midway.
Sites / Locations
- Xi'an No3 Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Group A (acupuncture group)
Group B (betahistine group)
Treatment patients with residual symptoms after successful manual repositioning by electroacupuncture
Treatment patients with residual symptoms after successful manual repositioning by oral betahistine